About
 
Modules
 
Tutorials
 
Contact
Home
Tools
Annotation
AnnoGen
Polytracts
SBSA
Database
SMDB
CoMutDB
MutMix
Gene Expression Analysis
Heatmap3
MetaGSCA
MultiRankSeq
Genotyping
Exome Chip Protocol
Illumina Array General Protocol
StrandScript
MutEx
Mutation Impact
Reverse Impact
Mutation Burden
Mutation Query
AESA
Differential Survival
EMSI
Co-Mutation
Proteomics
O18Quant
MHC Predictor
RNAseq Power Analysis
RnaSeq Sample Size
Sequence Analysis
EditPredict
Exon Del
GLMVC
MitoSeek
CPD-seq
Sequencing QC
DNA QC Protocols
QC3
RNA QC Protocols
People
Publication
About
 
Modules
 
Tutorials
 
Contact
Module:
Differential Survival
Step 1: Select Cancer type
Cancer type
Close
ACC: Adrenocortical Carcinoma (n=92)
BLCA: Bladder Urothelial Carcinoma (412)
BRCA: Breast Invasive Carcinoma (n=1098)
CESC: Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (n=307)
CHOL: Cholangiocarcinoma (n=51)
COAD: Colon Adenocarcinoma (n=461)
DLBC: Lymphoid Neoplasm Diffuse Large B-cell Lymphoma (n=58)
ESCA: Esophageal Carcinoma (n=185)
GBM: Glioblastoma Multiforme (n=617)
HNSC: Head and Neck Squamous Cell Carcinoma (n=528)
KICH: Kidney Chromophobe (n=113)
KIRC: Kidney Renal Clear Cell Carcinoma (n=537)
KIRP: Kidney Renal Papillary Cell Carcinoma(n=291)
LAML: Acute Myeloid Leukemia (n=200)
LGG: Brain Lower Grade Glioma (n=516)
LIHC: Liver Hepatocellular Carcinoma (n=377)
LUAD: Lung Adenocarcinoma (n=585)
LUSC: Lung Squamous Cell Carcinoma (n=504)
MESO: Mesothelioma (n=87)
OV: Ovarian Serous Cystadenocarcinoma (n=608)
PAAD: Pancreatic Adenocarcinoma (n=185)
PCPG: Pheochromocytoma and Paraganglioma (n=179)
PRAD: Prostate Adenocarcinoma (n=500)
READ: Rectum Adenocarcinoma (n=172)
SARC: Sarcoma (n=261)
SKCM: Skin Cutaneous Melanoma (n=470)
STAD: Stomach Adenocarcinoma (n=443)
TGCT: Testicular Germ Cell Tumors (n=150)
THCA: Thyroid Carcinoma (n=507)
THYM: Thymoma (n=124)
UCEC: Uterine Corpus Endometrial Carcinoma (n=560)
UCS: Uterine Carcinosarcoma (57)
UVM: Uveal Melanoma (80)
ACC
BLCA
BRCA
CESC
CHOL
COAD
DLBC
ESCA
GBM
HNSC
KICH
KIRC
KIRP
LAML
LGG
LIHC
LUAD
LUSC
MESO
OV
PAAD
PCPG
PRAD
READ
SARC
SKCM
STAD
TGCT
THCA
THYM
UCEC
UCS
UVM
Step 2: Analysis Options
Patient Groups
Survival
<=
%
Survival
>=
%
Pathway | GeneOntology
(
Optional selection; Runtime: ~1min per Cancer
)
KEGG
Wikipathway
Biological Process
Cellular Component
Molecular Function
DAVID